North Star Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,130
Closed -$190K 295
2018
Q2
$190K Sell
10,130
-3,247
-24% -$61.1K 0.02% 281
2018
Q1
$257K Hold
13,377
0.02% 248
2017
Q4
$263K Hold
13,377
0.02% 250
2017
Q3
$287K Hold
13,377
0.03% 214
2017
Q2
$279K Hold
13,377
0.03% 213
2017
Q1
$259K Hold
13,377
0.03% 210
2016
Q4
$227K Hold
13,377
0.03% 217
2016
Q3
$251K Sell
13,377
-2,150
-14% -$40.5K 0.03% 209
2016
Q2
$267K Sell
15,527
-265
-2% -$4.89K 0.03% 201
2016
Q1
$283K Sell
15,792
-1
-0% -$18 0.03% 197
2015
Q4
$373K Buy
15,793
+118
+0.8% +$2.93K 0.04% 187
2015
Q3
$353K Sell
15,675
-868
-5% -$24.3K 0.04% 192
2015
Q2
$467K Buy
16,543
+128
+0.8% +$3.55K 0.05% 186
2015
Q1
$453K Sell
16,415
-350
-2% -$9.54K 0.05% 186
2014
Q4
$417K Sell
16,765
-1,211
-7% -$29.1K 0.05% 188
2014
Q3
$397K Sell
17,976
-8,065
-31% -$175K 0.05% 192
2014
Q2
$541K Buy
26,041
+7,631
+41% +$160K 0.06% 172
2014
Q1
$400K Sell
18,410
-314
-2% -$6.99K 0.05% 186
2013
Q4
$383K Hold
18,724
0.05% 186
2013
Q3
$360K Sell
18,724
-4,601
-20% -$88.1K 0.05% 188
2013
Q2
$417K Buy
+23,325
New +$421K 0.06% 175

Other funds holding HQL

North Star Asset Management's HQL Position: Q3 2018 in Review

North Star Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q3 2018, closing a stake of 10,130 shares — an estimated $190K sold.

North Star Asset Management first reported a position in HQL in Q2 2013 and held it in 21 quarters. The position peaked at $541K in Q2 2014. 57 funds tracked by Wall St. Rank hold HQL as of Q3 2018.

  • North Star Asset Management reported no remaining abrdn Life Sciences Investors position as of Q3 2018 after selling out during the quarter.
  • North Star Asset Management sold 10,130 abrdn Life Sciences Investors shares in Q3 2018, an estimated $190K.
  • North Star Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 21 quarters.
  • North Star Asset Management's abrdn Life Sciences Investors position peaked at $541K in Q2 2014.
  • 57 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2018.

Based on North Star Asset Management's 13F filing for Q3 2018, filed 29 Oct 2018.